These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3660857)

  • 1. The effect of midazolam (Hypnovel) administration on antipyrine pharmacokinetics in humans.
    Allen JG; Alderson J; Galloway DB; Hallett C
    Xenobiotica; 1987 Jul; 17(7):875-9. PubMed ID: 3660857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bromazepam (Lexotan) administration on antipyrine pharmacokinetics in humans.
    Allen JG; Galloway DB; Ehsanullah RS; Ruane RJ; Bird HA
    Xenobiotica; 1984 Apr; 14(4):321-6. PubMed ID: 6147049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat.
    White SM; Allen JG; Altman JF
    Xenobiotica; 1987 Jul; 17(7):869-73. PubMed ID: 3660856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1995 Sep; 40(3):270-2. PubMed ID: 8527290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug interactions with misoprostol: effects on the pharmacokinetics of antipyrine and propranolol.
    Bennett PN; Fenn GC; Notarianni LJ
    Postgrad Med J; 1988; 64 Suppl 1():21-4. PubMed ID: 3138681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Apr; 79(4):362-70. PubMed ID: 16580904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
    Wermeling DP; Record KA; Kelly TH; Archer SM; Clinch T; Rudy AC
    Anesth Analg; 2006 Aug; 103(2):344-9, table of contents. PubMed ID: 16861415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipyrine kinetics following influenza vaccination.
    Simonet R; Descotes J; Evreux JC
    Int J Clin Pharmacol Res; 1986; 6(3):231-3. PubMed ID: 3744625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
    Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
    Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between antipyrine kinetics and the change in the seromucoid content of rat plasma under the influence of the immunomodulator levamisole].
    Kupchikov VV; Bender KI; Lutsevich AN; Gangnus VS
    Farmakol Toksikol; 1990; 53(5):55-8. PubMed ID: 2253753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
    Rogers JF; Morrison AL; Nafziger AN; Jones CL; Rocci ML; Bertino JS
    Clin Pharmacol Ther; 2002 Dec; 72(6):711-7. PubMed ID: 12496752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between grapefruit juice and midazolam in humans.
    Kupferschmidt HH; Ha HR; Ziegler WH; Meier PJ; Krähenbühl S
    Clin Pharmacol Ther; 1995 Jul; 58(1):20-8. PubMed ID: 7628179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.